Company Performance Metrics
- Beston Hamasur: CEO and Co-Founder
Biopromic is a medical device company specializing in the development of rapid point-of-care diagnostics and ultrasensitive. The company also focuses on the development of rapid point-of-care diagnostics for infectious disease detection as well as innovative reagents for diagnostic and therapeutic purposes. They also produce a wide range of
bacterial antigens or their functional analogs.
Biopromic’s proprietary technologies in sample preparation and high-sensitivity antibodies to improve the accessibility of accurate TB testing in low- and middle-income countries. It also specializes in the production of ultra-sensitive monoclonal antibodies targeted primarily against carbohydrate antigens derived from bacteria and viruses.
Biopromic was founded in 2016 and is headquartered in Solna, Stockholm, Sweden.
